Osivax Raises €10 Million in Series B Financing to Advance Influenza Vaccine Development Osivax, a biopharmaceutical company focused on developing vaccines for broad-spectrum protection against highly mutating respiratory viruses, has announced the successful first close of its Series B financing,…
Biocom California Honors Akilah Weber Pierson and Kent Lee as “Elected Officials of the Year” Biocom California, representing the California life science industry, has named California State Senator Akilah Weber Pierson, M.D., and San Diego City Council President Pro Tem…
GC Targets Turnaround with Strategic Focus on Cost Reduction and Revenue Growth PTT Global Chemical Public Company Limited has unveiled its ambitious strategic roadmap to overcome industry challenges and achieve sustainable growth. In response to the global economic volatility and…
New Partnership Expands Career Opportunities for CPS Students at Chicago Military Academy Chicago Public Schools (CPS) students are about to gain exciting new opportunities for career development, thanks to a groundbreaking partnership with ComEd and City Colleges of Chicago’s Dawson…
Axcend Unveils Full-Stack Chromatography System, Revolutionizing Liquid Chromatography Axcend®, the leader in compact capillary liquid chromatography, has announced the launch of its groundbreaking small-footprint, full-stack chromatography system, which allows scientists to perform High-Performance Liquid Chromatography (HPLC) anywhere. Built on the…
Kyocera to Highlight Ceramic and Sapphire Engineering Solutions at Pittcon 2025 Kyocera will present a range of cutting-edge ceramic and single-crystal sapphire engineering solutions at Pittcon 2025, set to take place in Boston, Massachusetts, from March 3rd to 5th. Pittcon,…
Seequent Launches Evo: Revolutionizing Geoscience Data Collaboration and Management Seequent, the Bentley Subsurface Company, has unveiled Seequent Evo, a cloud-based platform designed to centralize geoscience data and enhance collaboration across industries reliant on this data, particularly mining. With the ability…
Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Polycythemia Vera Introduction to the VERIFY StudyProtagonist Therapeutics, Inc. and Takeda have announced the successful topline results of the Phase 3 VERIFY study, which evaluated…
Personalis and Royal Marsden Study Advances Early-Stage Breast Cancer Detection with NeXT Personal® ctDNA Test ICR and Royal Marsden Study Highlights ctDNA Testing Introduction: Advancements in Breast Cancer DetectionPersonalis, Inc. has partnered with renowned researchers from The Institute of Cancer…
Quanterix Reaffirms Strategic and Financial Benefits of Akoya Biosciences Acquisition Introduction to the AcquisitionQuanterix Corporation, a leader in ultra-sensitive biomarker detection, has reiterated the compelling strategic and financial advantages of its proposed acquisition of Akoya Biosciences. This move is set…
Celltrion’s Avtozma® (CT-P47) Biosimilar Receives European Commission Approval Celltrion has announced that the European Commission (EC) has granted marketing authorization for Avtozma® (CT-P47), a biosimilar to RoActemra® (tocilizumab). Avtozma® is approved for all indications of its reference product, RoActemra®, including…
QIAGEN Files Lawsuit Against bioMérieux to Protect QuantiFERON Technology QIAGEN has taken legal action to protect its intellectual property (IP) by filing a lawsuit against bioMérieux S.A. for patent infringement. The lawsuit, lodged in the Local Division of the Court…